產(chǎn)品編號 | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價格 | 分子式 | 快速訂購 |
---|---|---|---|---|---|---|---|
201109-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(3,5-二苯基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C57H47O4P | |
201109-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(3,5-二苯基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C57H47O4P | |
201109-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(3,5-二苯基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C57H47O4P | |
201108-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(3,5-二苯基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C57H47O4P | |
201108-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(3,5-二苯基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C57H47O4P | |
201108-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(3,5-二苯基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C57H47O4P | |
201107-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(三苯基硅基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C57H51O4PSi2 | |
201107-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(三苯基硅基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C57H51O4PSi2 | |
201107-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(三苯基硅基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C57H51O4PSi2 | |
201106-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(三苯基硅基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C57H51O4PSi2 | |
201106-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(三苯基硅基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C57H51O4PSi2 | |
201106-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(三苯基硅基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C57H51O4PSi2 | |
201105-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(3,5-二氯苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C33H27Cl4O4P | |
201105-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(3,5-二氯苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C33H27Cl4O4P | |
201105-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(3,5-二氯苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C33H27Cl4O4P | |
201104-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(3,5-二氯苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C33H27Cl4O4P | |
201104-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(3,5-二氯苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C33H27Cl4O4P | |
201104-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(3,5-二氯苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C33H27Cl4O4P | |
201103-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(4-硝基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C33H29N2O8P | |
201103-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(4-硝基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C33H29N2O8P | |